Market Research Reports

Synthetic Biology Market (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019

143pages
Published Date: 2014-04-08
 

Description


Synthetic biology defined as the synthesis of artificial or natural components in order to form new artificial living system by re-molding existing biological elements. It aims to attain new preferred functions of artificially modified organisms intended for high yield production of biological systems. Synthetic biology plays an important role in the field of life sciences by developing cheap synthesis procedures. Increasing scientific research coupled with introduction of advanced technologies in synthetic biology will drive the growth of this market. The market for synthetic biology is segmented as: by products, by technologies and by applications. Product segment includes core products and enabling products. Core product segment comprises synthetic DNA, synthetic genes, synthetic cells, XNA and chassis organisms. While enabling products are segmented into DNA and oligonucleotide synthesis products.

Synthetic biology, by technologies segment is divided into genome engineering, DNA sequencing, bioinformatics and biological components and integrated systems. Application segment of synthetic biology market includes healthcare, chemicals, agriculture and others. This report covers participation of different organizations of the U.S. and the U.K. for the development of synthetic biology field. In addition, it explains various technological advancements taking place in each of these segments. The report includes market estimations of the global synthetic biology market in terms of value (USD million) for the period 2013 – 2019, considering 2012 as the base year. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global synthetic biology market. The report provides market size and forecasts for each segment and geographic region with CAGR % for the period from 2013 to 2019.

The market is also forecasted in terms of value (USD million) for the period 2013 – 2019 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the synthetic biology market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has been discussed in the study which would help in decision making.

Some of the key market players of the global synthetic biology market include Agrivida, Inc., Biosearch Technologies, Inc., DuPont, Inc., Evolva SA, Exxon Mobil Corporation and others. Market players are profiled in this report on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.

The global synthetic biology market is segmented into the following categories:
  • Synthetic Biology Market, by Products
    • Core Products
      • Synthetic DNA
      • Synthetic Genes
      • Synthetic Cells
      • XNA (Xeno Nucleic Acid)
      • Chasis Organisms
    • Enabling Products
      • DNA Synthesis
      • Oligonucleotide Synthesis
  • Synthetic Biology Market, by Technologies
    • Genome Engineering
    • DNA Sequencing
    • Bioinformatics
    • Biological Components and Integrated Systems
  • Synthetic Biology Market, by Applications
    • Healthcare
    • Chemicals (Including Bio-Fuels)
    • Agriculture
    • Others (Biosecurity, R&D, Energy and Environment)
  • Synthetic Biology Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)

Table of Contents


Table of Contents

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Synthetic Biology Market (2012 & 2019)
      2.1.1 Global Synthetic Biology Market by Technologies, 2012 (USD Million)
2.2 Comparative Analysis: Global Synthetic Biology Market, By Geography, 2012 and 2019 (Value %)

Chapter 3 Market Overview
3.1 Introduction
3.2 Market Drivers
      3.2.1 Drivers
               3.2.1.1 Rising demand for improved drugs and vaccines
               3.2.1.2 Advancement in molecular biology
               3.2.1.3 Encouragement and participation of government bodies and universities in synthetic biology research
               3.2.1.4 Increasing demand of genetically modified crops due to rising population
3.3 Market Restraints
      3.3.1 Ethical Issues
3.4 Market Opportunities
      3.4.1 Increasing clarity about metabolic pathways and nascent nature of synthetic biology concepts
3.5 Porter’s Five Force Analysis
      3.5.1 Bargaining Power of Suppliers
      3.5.2 Bargaining Power of Buyers
      3.5.3 Threat of Substitutes
      3.5.4 Threat of New Entrants
      3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Synthetic Biology Market, by Geography

Chapter 4 Global Synthetic Biology Market, by Products
4.1 Introduction
      4.1.1 Global Synthetic Biology Market Revenue, by Products, 2011 – 2019 (USD Million)
4.2 Core Products
      4.2.1 Global Core Products Market Revenue, by Types, 2011 – 2019 (USD Million)
      4.2.2 Synthetic DNA
               4.2.2.1 Global Synthetic DNA Market Revenue, 2011 – 2019 (USD Million)
      4.2.3 Synthetic Genes
               4.2.3.1 Global Synthetic Genes Market Revenue, 2011 – 2019 (USD Million)
      4.2.4 Synthetic Cells
              4.2.4.1 Global Synthetic Cells Market Revenue, 2013 – 2019 (USD Million)
      4.2.5 XNA (Xeno Nucleic Acid)
              4.2.5.1 Global XNA Market Revenue, 2014 – 2019 (USD Million)
      4.2.6 Chassis Organisms
               4.2.6.1 Global Chassis Organisms Market Revenue, 2015 – 2019 (USD Million)
4.3 Enabling Products
      4.3.1 Global Enabling Products Market Revenue, by Types, 2011 – 2019 (USD Million)
      4.3.2 DNA Synthesis
              4.3.2.1 Global DNA Synthesis Market Revenue, 2011 – 2019 (USD Million)
      4.3.3 Oligonucleotide Synthesis
              4.3.3.1 Global Oligonucleotide Synthesis Market Revenue, 2011 – 2019 (USD Million)

Chapter 5 Global Synthetic Biology Market, by Technologies
5.1 Introduction
      5.1.1 Global Synthetic Biology Market Revenue, by Technologies, 2011 – 2019 (USD Million)
5.2 Genome Engineering
      5.2.1 Global Genome Engineering in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
5.3 DNA Sequencing
      5.3.1 Global DNA Sequencing in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
5.4 Bioinformatics
      5.4.1 Global Bioinformatics in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
5.5 Biological Components and Integrated Systems
      5.5.1 Global Biological Components and Integrated Systems in Synthetic Biology Market revenue, 2011 – 2019 (USD Million)

Chapter 6 Global Synthetic Biology Market, by Applications
6.1 Introduction
      6.1.1 Global Synthetic Biology Market Revenue, by Applications, 2011 – 2019 (USD Million)
6.2 Chemicals
      6.2.1 Global Synthetic Biology in Chemicals, Market Revenue, 2011 – 2019 (USD Million)
6.3 Healthcare
      6.3.1 Global Synthetic Biology in Healthcare Market Revenue, 2011 – 2019 (USD Million)
6.4 Agriculture
      6.4.1 Global Synthetic Biology in Agriculture Market Revenue, 2011 – 2019 (USD Million)
6.5 Others (Biosecurity, R&D, Energy and Environment)
      6.5.1 Global Synthetic Biology in Other Applications Market Revenue, 2011 – 2019 (USD Million)

Chapter 7 Global Synthetic Biology Market, by Geography
7.1 Introduction
      7.1.1 Global Synthetic Biology Market Revenue, by Geography, 2011 – 2019 (USD Million)
7.2 North America
      7.2.1 North America Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
7.3 Europe
      7.3.1 Europe Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
7.4 Asia-Pacific
      7.4.1 Asia-Pacific Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
7.5 Rest of the World (RoW)
      7.5.1 RoW Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)

Chapter 8 Competitive Landscape
8.1 Heat Map Analysis for Key Market Players
      8.1.1 Amyris, Inc.
      8.1.2 DuPont, Inc.
      8.1.3 Royal DSM
      8.1.4 Evolva Holding
      8.1.5 Life Technologies Corporation
8.2 Heat Map Analysis of the Synthetic Biology Market, by Key Market Players, 2013

Chapter 9 Recommendations
9.1 Market Strategy for Success
      9.1.1 Focus on investing in research and development activities
      9.1.2 Strategic alliance, mergers and acquisitions
9.2 Barriers to be Considered
      9.2.1 Ethical issues associated with synthetic biology products

Chapter 10 Company Profiles
10.1 Agrivida, Inc.
       10.1.1 Company Overview
       10.1.2 Financial Overview
       10.1.3 Product Portfolio
       10.1.4 Business Strategies
       10.1.5 Recent Developments
10.2 Amyris, Inc.
       10.2.1 Company Profile
       10.2.2 Financial Overview
       10.2.3 Product Portfolio
       10.2.4 Business Strategies
       10.2.5 Recent Developments
10.3 Algenol Biofuels, Inc.
       10.3.1 Company Overview
       10.3.2 Financial Overview
       10.3.3 Product Portfolio
       10.3.4 Business Strategies
       10.3.5 Recent Developments
10.4 ATG:biosynthetics GmbH
       10.4.1 Company Overview
       10.4.2 Financial Overview
       10.4.3 Product Portfolio
       10.4.4 Business Strategies
       10.4.5 Recent Developments
10.5 Bayer AG
       10.5.1 Company Overview
       10.5.2 Financial Overview
       10.5.3 Product Portfolio
       10.5.4 Business Strategies
       10.5.5 Recent Developments
10.6 Bristol-Myers Squibb
       10.6.1 Company Overview
       10.6.2 Financial Overview
       10.6.3 Product Portfolio
       10.6.4 Business Strategies
       10.6.5 Recent Developments
10.7 BIONEER CORPORATION
       10.7.1 Company Overview
       10.7.2 Product Portfolio
       10.7.3 Business Strategies
       10.7.4 Recent Developments
10.8 Biosearch Technologies, Inc.
       10.8.1 Company Overview
       10.8.2 Financial Overview
       10.8.3 Product Portfolio
       10.8.4 Business Strategies
       10.8.5 Recent Developments
10.9 CBC Comprehensive Biomarker Center GmbH
       10.9.1 Company Overview
       10.9.2 Financial Overview
       10.9.3 Product Portfolio
       10.9.4 Business Strategies
       10.9.5 Recent Developments
10.10 Cobalt Technologies
       10.10.1 Company Overview
       10.10.2 Financial Overview
       10.10.3 Product Portfolio
       10.10.4 Business Strategies
       10.10.5 Recent Developments
10.11 DuPont, Inc.
       10.11.1 Company Overview
       10.11.2 Financial Overview
       10.11.3 Product Portfolio
       10.11.4 Business Strategies
       10.11.5 Recent Developments
10.12 Evolva SA
       10.12.1 Company Overview
       10.12.2 Financial Overview
       10.12.3 Product Portfolio
       10.12.4 Business Strategies
       10.12.5 Recent Developments
10.13 Exxon Mobil Corporation
       10.13.1 Company Overview
       10.13.2 Financial Overview
       10.13.3 Product Portfolio
       10.13.4 Business Strategies
       10.13.5 Recent Developments
10.14 Ginkgo Bioworks
       10.14.1 Company Overview
       10.14.2 Financial Overview
       10.14.3 Product Portfolio
       10.14.4 Business Strategies
       10.14.5 Recent Developments
10.15 GeneWorks Pty Ltd.
       10.15.1 Company Overview
       10.15.2 Financial Overview
       10.15.3 Product Portfolio
       10.15.4 Business Strategies
       10.15.5 Recent Developments
10.16 Genomatica, Inc.
       10.16.1 Company Overview
       10.16.2 Financial Overview
       10.16.3 Product Portfolio
       10.16.4 Business Strategies
       10.16.5 Recent Developments
10.17 GeneScript Corporation
       10.17.1 Company Overview
       10.17.2 Financial Overview
       10.17.3 Product Portfolio
       10.17.4 Business Strategies
       10.17.5 Recent Developments
10.18 Gevo, Inc.
       10.18.1 Company Overview
       10.18.2 Financial Overview
       10.18.3 Product Portfolio
       10.18.4 Business Strategies
       10.18.5 Recent Developments
10.19 Green Biologics Limited
       10.19.1 Company Overview
       10.19.2 Financial Overview
       10.19.3 Product Portfolio
       10.19.4 Business Strategies
       10.19.5 Recent Developments
10.20 New England Biolabs, Inc.
       10.20.1 Company Overview
       10.20.2 Financial Overview
       10.20.3 Product Portfolio
       10.20.4 Business Strategies
       10.20.5 Recent Developments
10.21 OriGene Technologies, Inc.
       10.21.1 Company Overview
       10.21.2 Financial Overview
       10.21.3 Product Portfolio
       10.21.4 Business Strategies
       10.21.5 Recent Developments
10.22 REG Life Sciences, LLC
       10.22.1 Company Overview
       10.22.2 Financial Overview
       10.22.3 Product Portfolio
       10.22.4 Business Strategies
       10.22.5 Recent Developments
10.23 Royal DSM
       10.23.1 Company Overview
       10.23.2 Financial Overview
       10.23.3 Product Portfolio
       10.23.4 Business Strategies
       10.23.5 Recent Developments
10.24 Thermo Fisher Scientific, Inc.
       10.24.1 Company Overview
       10.24.2 Financial Overview
       10.24.3 Product Portfolio
       10.24.4 Business Strategies
       10.24.5 Recent Developments

List of Figures

FIG. 1 Synthetic Biology Market Segmentation
FIG. 2 Global Synthetic Biology Market, by Technologies, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Synthetic Biology Market, by Geography, 2012 and 2019 (Value %)
FIG. 4 Porter’s Five Forces Analysis: Global Synthetic Biology Market
FIG. 5 Market Attractiveness Analysis: Global Synthetic Biology Market, by Geography
FIG. 6 Global Synthetic DNA Market Revenue, 2011 – 2019 (USD Million)
FIG. 7 Global Synthetic Genes Market Revenue, 2011 – 2019 (USD Million)
FIG. 8 Global Synthetic Cells Market Revenue, 2013 – 2019 (USD Million)
FIG. 9 Global XNA Market Revenue, 2014 – 2019 (USD Million)
FIG. 10 Global Chassis Organisms Market Revenue, 2015 – 2019 (USD Million)
FIG. 11 Global DNA Synthesis Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Oligonucleotide Synthesis Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Global Genome Engineering in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Global DNA Sequencing in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 Global Bioinformatics in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Biological Components and Integrated Systems in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 Global Synthetic Biology in Chemicals Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Global Synthetic Biology in Healthcare Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 Global Synthetic Biology in Agriculture Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Global Synthetic Biology in Other Applications Market Revenue, 2011 – 2019 (USD Million)
FIG. 21 North America Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
FIG. 22 Europe Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
FIG. 23 Asia-Pacific Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
FIG. 24 RoW Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
FIG. 25 Heat Map Analysis of the Synthetic Biology Market, by Key Market Players, 2013
FIG. 26 Amyris, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 Bayer AG: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 28 Bristol-Myers Squibb: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 29 DuPont, Inc.: Annual Revenue, 2010– 2012 (USD Million)
FIG. 30 Evolva SA: Annual Sales, 2010 – 2012 (USD Million), 1 CHF = 1.13 USD
FIG. 31 Exxon Mobil Corporation: Annual Sales, 2010 – 2012 (USD Billion)
FIG. 32 Gevo, Inc.: Annual Sales, 2010 – 2012 (USD Million)
FIG. 33 Renewable Energy Group, Inc.: Annual Sales, 2011 – 2013 (USD Million)
FIG. 34 Royal DSM: Annual Revenue, 2010– 2012 (USD Million)
FIG. 35 Thermo Fisher Scientific, Inc.: Annual Revenue, 2010 – 2012 (USD Million)

List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Synthetic Biology Market (2012 & 2019)
TABLE 3 Global Synthetic Biology Market Revenue, by Products, 2011 – 2019 (USD Million)
TABLE 4 Global Core Products Market Revenue, by Types, 2011 – 2019 (USD Million)
TABLE 5 Global Enabling Products Market Revenue, by Types, 2011 – 2019 (USD Million)
TABLE 6 Global Synthetic Biology Market Revenue, by Technologies, 2011 – 2019 (USD Million)
TABLE 7 Global Synthetic Biology Market Revenue, by Applications, 2011 – 2019 (USD Million)
TABLE 8 U.S. Bio-fuels Pipeline Products, by Organizations
TABLE 9 Developed Drugs and Vaccines Utilizing the Concept of Synthetic Biology
TABLE 10 Global Synthetic Biology Market Revenue, by Geography, 2011 – 2019 (USD Million)
TABLE 11 List of Organizations and their Synthetic Biology Products and Applications

Enquiry Before Buying


Free Market Analysis


Synthetic biology is a synergistic combination of biology and engineering for the construction of artificial biological system in order to gain desired functions (i.e. to reduce cost or improve efficacy). It comprises nascent technologies that enable synthesis of novel biological parts and organisms that are used in the field of healthcare, chemicals, agriculture and others (biosecurity, R&D and energy and environment). The synthetic biology market is witnessing rapid growth owing to increase in demand for renewable fuels and bio-based chemicals and inexpensive drugs and vaccines that utilizes synthetic biology technologies and products. In addition, participation of various organizations such as BioBricks, DIYbio and SynBERC, for the development of synthetic biology field will further augment the growth of this market during the forecast period. However, high cost and strict regulations to use synthetic biology techniques hampers the growth of this market. The global synthetic biology market is estimated to be USD 1,769.8 million in 2012 and is expected to reach USD 13,375.5 million by 2019, growing at a CAGR of 32.6% from 2013 to 2019. 

Synthetic biology market is segmented mainly by products, by technologies and by applications. Synthetic biology, by product segment is classified as core products and enabling products. Core products are further segmented into synthetic DNA, synthetic genes, synthetic cells, XNA and chassis organisms. The synthetic biology market by core products was dominated by synthetic DNA market in 2012 owing to the commercial availability of this product, compared to other synthetic core products expected to be launched in the market in coming years. 
Synthetic biology market, by technologies is segmented as genome engineering, DNA sequencing, bioinformatics and biological components and integrated systems. Genome engineering technology can be used to modify genetic foods, gene cloning and gene therapy. Thus, application of genome engineering increases the scope to utilize this technique and hence accentuates the growth of this market.

Applications of synthetic biology are healthcare, chemicals, agriculture and others. Synthetic biology in healthcare holds largest market share in terms of revenue due to high utilization of synthetic biology techniques to produce cheap drugs and vaccines. Also, commercial availability of synthetic DNA and synthetic genes supports the growth of the healthcare application in the synthetic biology market. Agriculture segment is expected to grow at the highest growth rate during the forecast period.

Europe contributed the largest share of the global synthetic biology market in 2012 and is expected to grow consistently, owing to increasing efforts of government and private organizations towards the development of this field. North America contributed the second largest share of the total market in 2012. Introduction of novel technologies by will help the growth of this market in North America. The Asia-Pacific region is expected to witness the fastest growth due to support of international organizations (e.g. Biotechnology Industry Organization and others) for the growth of synthetic biology in Asia-Pacific.

In terms of key players, the global synthetic biologymarket is highly fragmented with presence of a large number of players that includeBristol Mayer, Gevo, Inc., Life Technologies, DSM, DuPont, Inc., Genomatica, Inc., LS9, Inc.,Amyris, Inc. and others.

global-synthetic-biology-market-by-technologies-2012
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research